Chris Markoch, Editor & Contributing Author at MarketBeat Articles by Chris Markoch - Page 5July 16, 2024 4:55 AM ETCan This AI Stock Keep Driving the Market Higher?Chris MarkochNVIDIA is one of the best-performing stocks in 2024 due to demand for AI applications, but there are reasons to ask how long it will move the market higherNASDAQ:NVDANASDAQ:MSFTNASDAQ:METARead Can This AI Stock Keep Driving the Market Higher?July 15, 2024 5:00 AM ETPositive News is Driving This Cancer Drug Maker’s Stock HigherChris MarkochIDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather NASDAQ:IDYANYSE:LLYNYSE:PFERead Positive News is Driving This Cancer Drug Maker’s Stock HigherJuly 10, 2024 9:03 AM ETAI Partnership Boosts This Top Tech Stock: Ready for More Gains?Chris MarkochPalantir stock is one of the best-performing stocks in 2024, and investors wonder if it has room to run higher; recent developments suggest it mayNYSE:PLTRNASDAQ:NVDANYSE:ORCLRead AI Partnership Boosts This Top Tech Stock: Ready for More Gains?July 5, 2024 6:41 AM ETTop 3 Retail Stocks Defying the Earnings Trend: AEO, PLAY, ROSTChris MarkochThe broader retail sector is under pressure, but these three retail stocks are beating earnings estimates and continue to issue bullish forecastsNASDAQ:LULUNYSE:AEONASDAQ:PLAYRead Top 3 Retail Stocks Defying the Earnings Trend: AEO, PLAY, ROSTJuly 3, 2024 10:45 AM ETAbbVie Stock: A Perfect Dip for Investors to BuyChris MarkochABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investorsNYSE:ABBVNYSE:JNJNYSE:PFERead AbbVie Stock: A Perfect Dip for Investors to BuyJuly 2, 2024 7:05 AM ETThe Top 4 Magnificent 7 Stocks to Buy in the Year's Second HalfChris MarkochAs investors rotated out of NVDA, they rotated into other Magnificent 7 stocks, which could continue their rally in the second half of 2024NASDAQ:AMZNNASDAQ:METANASDAQ:AAPLRead The Top 4 Magnificent 7 Stocks to Buy in the Year's Second HalfJune 27, 2024 5:04 AM ETAny Pullback in Tech May Signal a Rotation into These 3 SectorsChris MarkochInvestors who believe in diversification are waiting for the market to broaden out; instead of watching the Fed, look at the sectors institutions are buyingNASDAQ:NVDANASDAQ:MSFTNYSEARCA:XLERead Any Pullback in Tech May Signal a Rotation into These 3 SectorsJune 18, 2024 5:15 AM ET3 Strong Buy Stocks for a Sizzling Summer RallyChris MarkochInvestors can take a deep breath before the next earnings season, but they should still invest in equities, including these three gems hiding in plain sightNASDAQ:MSFTNASDAQ:NVDANASDAQ:AVGORead 3 Strong Buy Stocks for a Sizzling Summer RallyJune 17, 2024 9:51 AM ETBuffett Bails on BYD: What It Means for the Future of EV StocksChris MarkochWarren Buffett's hedge fund Berkshire-Hathaway continues to reduce its position in BYD stock, renewing concerns about Buffett's outlook on the EV industryOTCMKTS:BYDDYNYSE:BRK.BNASDAQ:TSLARead Buffett Bails on BYD: What It Means for the Future of EV StocksJune 14, 2024 5:05 AM ET3 High-Yield Dividend Stocks for Income Now and Growth LaterChris MarkochBuying high-yield dividend stocks at a low price today gives you current income with the opportunity for growth when interest rates come down later this yearNYSE:CVXNYSE:HESNYSE:BMYRead 3 High-Yield Dividend Stocks for Income Now and Growth LaterJune 12, 2024 5:35 AM ETBeyond GME: Top 3 WallStreetBets Stocks Better Than GameStopChris MarkochYou may want to keep an eye on the stocks the WallStreetBets community is watching; here are three that look like solid stocks to ownNYSE:AINASDAQ:CRWDNASDAQ:LULURead Beyond GME: Top 3 WallStreetBets Stocks Better Than GameStopJune 10, 2024 7:15 AM ETPalantir Was Left Out of the S&P 500; It Still Looks Like a BuyChris MarkochPalantir stock dropped about 2% after news that it will not be added to the S&P 500, but despite the short-term setback, PLTR is still a solid long-term buyNYSE:PLTRNASDAQ:CRWDNYSE:GDDYRead Palantir Was Left Out of the S&P 500; It Still Looks Like a BuyJune 7, 2024 5:52 AM ETChevron Stock Concerns: Perspectives Make the DifferenceChris MarkochAlthough Chevron has underperformed the broader market in the past 12 months, CVX stock is still a good buy for long-term investorsNYSE:CVXNYSE:XOMNYSE:HESRead Chevron Stock Concerns: Perspectives Make the DifferenceJune 4, 2024 7:55 AM ETBirkenstock Looks Like a Fit in Any Growth-Oriented PortfolioChris MarkochBirkenstock is trading close to its fair valuation after a 14% gain in the five days surrounding its earnings report, but investors will be able to buy any dipNYSE:BIRKNASDAQ:CROXNASDAQ:LULURead Birkenstock Looks Like a Fit in Any Growth-Oriented PortfolioMay 31, 2024 5:35 AM ETHormel: A Potential Buy Despite Post-Earnings DeclineChris MarkochHormel stock is down sharply after a mixed earnings report, however, long-term investors can still cash in on the company's high-yield dividendNYSE:HRLRead Hormel: A Potential Buy Despite Post-Earnings DeclineMay 30, 2024 10:07 AM ETPure Storage Stock Spikes and Analysts are Jumping on BoardChris MarkochPure Storage stock is moving higher after a solid earnings report that is prompting analysts to bid PSTG stock higher; there could be as much as 28% upsideNYSE:PSTGRead Pure Storage Stock Spikes and Analysts are Jumping on BoardMay 13, 2024 9:10 AM ETGameStop is Roaring Based on Speculation Not SubstanceChris MarkochTrading on GME stock was halted after the stock jumped 110% higher, but the spike is being fueled by fantasy for a short squeeze, not fundamentalsNYSE:GMENASDAQ:HOODRead GameStop is Roaring Based on Speculation Not SubstanceMay 13, 2024 5:30 AM ETRocket Lab Stock Drops but Could Still Launch HigherChris MarkochThe dip in Rocket Lab stock after earnings has erased a year of gains, but growing revenue could make this a buying opportunity for risk-tolerant investorsNASDAQ:RKLBRead Rocket Lab Stock Drops but Could Still Launch HigherMay 13, 2024 5:15 AM ETAnheuser-Busch Continues Its Push to Retake the CrownChris MarkochBUD stock rose 7% the week after the company reported solid earnings and expects the Bud Light backlash to be over, but a weak consumer may be a bigger concernNYSE:BUDNYSE:STZRead Anheuser-Busch Continues Its Push to Retake the CrownMay 13, 2024 5:00 AM ETEvolv Technologies Had a Bad Week, Is it Time to Buy or Fade?Chris MarkochEVLV stock fell more than 30% on news that the company is the target of a class-action lawsuit; the news made a bad earnings report look worse than it wasNASDAQ:EVLVRead Evolv Technologies Had a Bad Week, Is it Time to Buy or Fade?May 7, 2024 7:16 AM ETTraders Sell but Investors Still Win After Palantir's EarningsChris MarkochPalantir stock is down sharply after a strong earnings report. The long-term thesis hasn't changed, but it reinforces that PLTR stock is still an active tradeNYSE:PLTRRead Traders Sell but Investors Still Win After Palantir's EarningsMay 3, 2024 7:28 AM ETApple’s Earnings Show Investors Its Strength and Its WeaknessChris MarkochApple stock is up after the company announced a $110 billion share buyback; however, the report did not provide clarity about the company’s direction on AINASDAQ:AAPLNASDAQ:GOOGLRead Apple’s Earnings Show Investors Its Strength and Its WeaknessMay 3, 2024 5:18 AM ETFor Cardinal Health, the Proof Will be in Its PerformanceChris MarkochCAH stock is up after mixed earnings that investors hope is enough to hold support after the company announced its contract for OptumRx will expire in JuneNYSE:CAHNYSE:UNHNYSE:WFCRead For Cardinal Health, the Proof Will be in Its PerformanceApril 30, 2024 7:10 AM ETAnalyst Sentiment, Revenue Growth Will Lead AbbVie Stock HigherChris MarkochAfter falling nearly 6% based on concerns about Humira sales, AbbVie stock is recovering, and bullish analyst sentiment is likely to push the stock higherNYSE:ABBVRead Analyst Sentiment, Revenue Growth Will Lead AbbVie Stock Higher Page 5 of 40 « Most Recent‹ More Recent2345678 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
